Global Anunal used in Research and Testing Market Size By Type (Rat, Mice), By Application (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies), By Region, And Segment Foreca...

The Global Animals Used in Research and Testing Market was valued at USD 8.3 billion in 2023 and is anticipated to reach USD 13.7 billion by 2031, growing at a CAGR of 6.5% during the forecast period from 2023 to 2031. The market is propelled by the ongoing advancements in biomedical research, regulatory mandates for preclinical testing, and the increasing application of animals in pharmaceutical, biotechnology, and academic research. Laboratory animals remain integral to drug discovery, toxicity testing, disease modeling, and genetic studies, playing a foundational role in scientific progress across various sectors.

Drivers:

1. Growth in Pharmaceutical and Biotechnology R&D:

Pharmaceutical and biotech companies increasingly rely on animal models to evaluate drug efficacy and safety before progressing to human trials, boosting demand for lab animals.

2. Rising Prevalence of Chronic and Genetic Disorders:

The growing burden of diseases like cancer, diabetes, and neurological disorders necessitates advanced research for innovative therapies, which is supported by animal testing.

3. Expansion of Academic and Government Research Initiatives:

Academic institutions and public sector organizations continue to invest in biomedical and behavioral research, further driving the use of animals in scientific exploration.

Restraints:

1. Ethical and Regulatory Pressures:

Stringent animal welfare regulations, growing ethical concerns, and advocacy by animal rights organizations are restraining unrestricted use and increasing oversight.

2. Emergence of Alternatives to Animal Testing:

The development and adoption of alternative models such as organ-on-chip, computer simulations, and in vitro testing are gradually impacting market dynamics.

Opportunity:

1. Demand in Emerging Economies:

Countries in Asia-Pacific and Latin America are witnessing increased government and private sector funding for biomedical research, creating new growth avenues.

2. Innovations in Genetic Engineering and Transgenic Models:

Breakthroughs in gene-editing technologies such as CRISPR are enabling the creation of more precise animal models for disease research, expanding the market's potential.

Market by System Type Insights:

Based on system type, the Rodents segment (including mice and rats) held the dominant market share in 2023. Rodents are widely preferred due to their genetic similarity to humans, short life cycles, and ease of handling. They are primarily used in oncology, neuroscience, and toxicology studies. However, the Non-Rodents segment—including primates, canines, and pigs—is expected to experience faster growth due to their relevance in translational and regulatory testing.

Market by End-use Insights:

The Pharmaceutical & Biotechnology Companies segment accounted for the largest share in 2023, driven by the industry's robust pipeline of new drug candidates and increasing reliance on animal models for safety and efficacy testing. Academic Research Institutions follow closely, benefiting from government-funded initiatives and collaborative research programs.

Market by Regional Insights:

North America led the global market in 2023, supported by a mature pharmaceutical industry, well-established research infrastructure, and high R&D expenditure. Europe followed closely, with significant contributions from the UK, Germany, and France. Asia-Pacific is projected to be the fastest-growing region due to expanding research capabilities in China, India, and South Korea, coupled with favorable funding and investment trends.

Competitive Scenario:

Key players in the market include Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, GenOway, Janvier Labs, and Marshall BioResources. These companies are actively investing in breeding programs, strategic collaborations, and the expansion of specialized genetically modified animal models.

Key Market Developments:

2023: Charles River Laboratories partnered with a leading biotech firm to supply specialized disease models for immunotherapy research.

2024: Taconic Biosciences launched a new line of microbiome-optimized rodent models tailored for gastrointestinal studies.

2025: Jackson Laboratory expanded its genetic research portfolio with AI-integrated phenotyping technologies for transgenic mice.

Scope of Work – Global Animals Used in Research and Testing Market

Report Metric Details

Market Size (2023) USD 8.3 billion

Projected Market Size (2031) USD 13.7 billion

CAGR (2023–2031) 6.5%

Market Segments By System Type (Rodents, Non-Rodents), By End-use

Growth Drivers Rising R&D in pharma, chronic disease prevalence

Opportunities Emerging markets, genetic model innovation

FAQs:

1) What is the current market size of the Global Animals Used in Research and Testing Market?

The market was valued at USD 8.3 billion in 2023.

2) What is the major growth driver of the Global Animals Used in Research and Testing Market?

The primary growth driver is the increasing demand for animal models in pharmaceutical and biotechnology research and development.

3) Which is the largest region during the forecast period in the Global Animals Used in Research and Testing Market?

North America holds the largest share due to its robust R&D infrastructure and high investment in biomedical research.

4) Which segment accounted for the largest market share in Global Animals Used in Research and Testing Market?

The Rodents segment held the largest share in 2023 due to widespread usage in various types of preclinical studies.

5) Who are the key market players in the Global Animals Used in Research and Testing Market?

Key players include Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, GenOway, and Janvier Labs.